The programmed cell death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors are immune checkpoint inhibitors (ICPs) that block the cancer cell's ability to evade the tumor-specific cytotoxic T lymphocytes (CTLs). The gene discussed is CD274; the disease is cancer.